Indoco Remedies Limited
NSE: INDOCO.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Suresh Govind Kare
- Employees
- 6,000
- Headquarters
- Mumbai, India
- IPO year
- 2005
- Market cap
- ₹21.0B
- Website
- https://www.indoco.com
Loading INDOCO…
Loading profile data…Frequently asked questions about INDOCO
What does Indoco Remedies Limited (INDOCO.NS) do?
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform D...
Where does INDOCO.NS trade?
Indoco Remedies Limited (INDOCO.NS) trades on the National Stock Exchange of India.
What sector is INDOCO.NS in?
Indoco Remedies Limited (INDOCO.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Indoco Remedies Limited?
Suresh Govind Kare is the chief executive officer of Indoco Remedies Limited (INDOCO.NS).
Where is Indoco Remedies Limited headquartered?
Indoco Remedies Limited is headquartered in India.
Does INDOCO.NS pay a dividend?
Yes — Indoco Remedies Limited (INDOCO.NS) paid a trailing twelve-month dividend of INR 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did INDOCO.NS go public?
Indoco Remedies Limited (INDOCO.NS) completed its initial public offering in 2005.